This is an exciting time for leukemia research, with the latest research using bispecifics revealing positive outcomes for patients. Here, Prof. John DiPersio, MD, PhD of Washington University School of Medicine, Washington, WA describes future plans to expand a study using bispecifics to treat patients with acute myeloid leukemia. This interview was recorded at the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Haematology (ESH).
